Mesenchymal stem cells (MSCs) are a type of non-controversial, adult cell. When manipulated within a laboratory, then can be differentiated into the specialized cells found in skeletal tissues, such as cartilage cells (chondrocytes), bone cells (osteoblasts), and fat cells (adipocytes). In contrast, stem cells derived from embryos are capable of developing into all the different types of cells found in our body, which makes them more versatile than MSCs, but also more controversial. Induced pluripotent stem cells also exhibit greater pluripotency, but as modified cells, they come with a greater set of regulatory challenges. [Read more…]
Stem Cell Hair Transplants in 2026: How Fat-Derived Stem Cells Are Transforming Hair Restoration
For over a decade, platelet-rich plasma (PRP) dominated the minimally invasive hair restoration space. Its appeal lay in its simplicity: draw blood, spin it, inject the growth-factor-rich plasma back into the scalp. But while PRP sparked interest and delivered early signs of improvement, its limitations have become clearer over time. Many patients require repeated sessions, results vary widely, and follicular stimulation often plateaus. [Read more…]
Stem Cell Treatment For Hair Loss in 2026
The latest development in stem cell research – stem cell treatment for hair loss – shows great promise for stimulating new hair growth. It addresses the problem of thinning hair for both men and women.
When hair growth slows with age, many people feel despondent, depressed, less confident, or unhappy. The prospect of a continuing downhill slide makes the situation worse, which is why stem cell transplant for hair loss has become a large business in the last several decades. [Read more…]
CHU Toulouse and Cell-Easy Launch A-MUSE, a Phase 1/2 Clinical Trial Evaluating the CellReady® Allogeneic MSC Platform in Systemic Sclerosis
Toulouse, January 22, 2026 — Cell-Easy, a CDMO specialized in the development and GMP manufacturing of Advanced Therapy Medicinal Products (ATMPs), announces a new clinical milestone achieved in close collaboration with Toulouse University Hospital (CHU Toulouse). The European Medicines Agency (EMA) has granted Clinical Trial Authorization (CTA) for AMUSE, a Phase 1/2 clinical trial evaluating the safety and efficacy of an allogeneic mesenchymal stromal cell (MSC) therapy in patients with systemic sclerosis presenting perioral fibrosis and functional impairment. [Read more…]
Embryonic Stem Cells – Definition, Uses, and Limitations
Embryonic stem cells are cells that can give rise to all of the tissues types that form a human being. These stem cells are being used in drug development, toxicology testing, and disease reversal, as well as to grow healthy new tissue to heal injuries.
While they are powerful cells, embryonic stem cells are controversial to produce, because they are created from human embryos. For this reason, they have limited use and receive restricted funding. Learn more about these cells below. [Read more…]
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 200
- Next Page »